Skip to main content
. 2020 Feb 9;5(1):e000573. doi: 10.1136/esmoopen-2019-000573

Table 1.

OX40-targeted drugs

Type Drug
Humanised IgG1 agonist mAb ABBV-368
GSK3174998
MEDI0562
MOXR0916 (vonlerolizumab)
Fully human IgG1 agonist mAb INCAGN01949
IBI101
BMS-986178
Fully human IgG2 agonist Ab PF-04518600
Murine IgG1 agonist mAb MEDI6469P
9B12
Human IgG1 CTLA-4 × OX40 bispecific Ab ATOR-1015
Lipid nanoparticle encapsulating mRNAs encoding human OX40L, IL-23 and IL-36γ mRNA-2752
Human OX40L IgG4P Fc fusion protein MEDI6383
Dual-sided Fc fusion protein PD1-Fc-OX40L SL-279252

Ab, antibodies; IL, interleukin; mAb, monoclonal antibodies.